Nuclear Medicine Prepares for Greater 68Ga Demand Nuclear Medicine Prepares for Greater 68Ga Demand

The recent FDA approval of Gallium-68 prostate-specific membrane antigen has resulted in unprecedented demand and a ramping up of its production and associated components by several companies.Applied Radiology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Radiology Journal Article Source Type: news